Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Immunology of Diabetes Society T-Cell Workshop: HLA class II tetramer-directed epitope validation initiative.

James EA, Mallone R, Schloot NC, Gagnerault MC, Thorpe J, Fitzgerald-Miller L, Reichow J, Wagner R, Pham MN, Jospe N, Lou O, Gottlieb PA, Brooks-Worrell BM, Durinovic-Belló I; T-Cell Workshop Committee, Immunology of Diabetes Society.

Diabetes Metab Res Rev. 2011 Nov;27(8):727-36. doi: 10.1002/dmrr.1244.

PMID:
22069252
2.

Immunology of Diabetes Society T-Cell Workshop: HLA class I tetramer-directed epitope validation initiative T-Cell Workshop Report-HLA Class I Tetramer Validation Initiative.

Mallone R, Scotto M, Janicki CN, James EA, Fitzgerald-Miller L, Wagner R, Gottlieb P, Thorpe J, Jospe N, Durinovic-Bellò I, Boitard C, Lou O, Dayan CM, Wong FS; T-Cell Workshop Committee, Immunology of Diabetes Society.

Diabetes Metab Res Rev. 2011 Nov;27(8):720-6. doi: 10.1002/dmrr.1243.

PMID:
22069251
3.

Recognition of Ii-Key/MHC class II epitope hybrids derived from proinsulin and GAD peptides by T cells in type 1 diabetes.

Vadacca M, Valorani MG, von Hofe E, Kallinteris NL, Buzzetti R, Pozzilli P.

Horm Metab Res. 2011 Jun;43(7):483-8. doi: 10.1055/s-0031-1275705. Epub 2011 Apr 21.

PMID:
21512962
4.

GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects.

Oling V, Marttila J, Ilonen J, Kwok WW, Nepom G, Knip M, Simell O, Reijonen H.

J Autoimmun. 2005 Nov;25(3):235-43. Epub 2005 Nov 2. Erratum in: J Autoimmun. 2006 Aug;27(1):69.

PMID:
16263242
5.

Predominantly recognized proinsulin T helper cell epitopes in individuals with and without islet cell autoimmunity.

Durinovic-Belló I, Boehm BO, Ziegler AG.

J Autoimmun. 2002 Feb;18(1):55-66.

PMID:
11869047
6.

HLA class I epitope discovery in type 1 diabetes.

van Endert P, Hassainya Y, Lindo V, Bach JM, Blancou P, Lemonnier F, Mallone R.

Ann N Y Acad Sci. 2006 Oct;1079:190-7.

PMID:
17130554
7.

CD4+ T cells from type 1 diabetic and healthy subjects exhibit different thresholds of activation to a naturally processed proinsulin epitope.

Yang J, Danke N, Roti M, Huston L, Greenbaum C, Pihoker C, James E, Kwok WW.

J Autoimmun. 2008 Aug;31(1):30-41. doi: 10.1016/j.jaut.2008.02.001. Epub 2008 Apr 2.

PMID:
18385016
8.

Activated human epitope-specific T cells identified by class II tetramers reside within a CD4high, proliferating subset.

Novak EJ, Masewicz SA, Liu AW, Lernmark A, Kwok WW, Nepom GT.

Int Immunol. 2001 Jun;13(6):799-806.

PMID:
11369708
9.

Use of HLA-DR*08032/E7 and HLA-DR*0818/E7 tetramers in tracking of epitope-specific CD4+ T cells in active and convalescent tuberculosis patients compared with control donors.

Li Y, Zhu Y, Zhou L, Fang Y, Huang L, Ren L, Peng Y, Li Y, Yang F, Xie D, Tang W, Zhang N, Zhong Q, Lai X.

Immunobiology. 2011 Aug;216(8):947-60. doi: 10.1016/j.imbio.2011.01.003. Epub 2011 Jan 12.

PMID:
21281984
10.

Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes.

Harcourt GC, Lucas M, Sheridan I, Barnes E, Phillips R, Klenerman P.

J Viral Hepat. 2004 Jul;11(4):324-31.

PMID:
15230855
12.

Comparison between major histocompatibility complex class II tetramer staining and surface expression of activation markers for the detection of allergen-specific CD4⁺ T cells.

Bonvalet M, Wambre E, Moussu H, Horiot S, Kwok WW, Louise A, Ebo D, Hoarau C, Van Overtvelt L, Baron-Bodo V, Moingeon P.

Clin Exp Allergy. 2011 Jun;41(6):821-9. doi: 10.1111/j.1365-2222.2011.03708.x. Epub 2011 Mar 21.

PMID:
21418343
13.

Immune responses to a class II helper peptide epitope in patients with stage III/IV resected melanoma.

Wong R, Lau R, Chang J, Kuus-Reichel T, Brichard V, Bruck C, Weber J.

Clin Cancer Res. 2004 Aug 1;10(15):5004-13.

14.

Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma.

Jäger E, Jäger D, Karbach J, Chen YT, Ritter G, Nagata Y, Gnjatic S, Stockert E, Arand M, Old LJ, Knuth A.

J Exp Med. 2000 Feb 21;191(4):625-30.

15.
16.

Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.

Roep BO, Atkinson MA, van Endert PM, Gottlieb PA, Wilson SB, Sachs JA.

J Autoimmun. 1999 Sep;13(2):267-82.

PMID:
10479395
17.

Beta-cell reactive T-cell clones from type I diabetes patients are not beta cell specific and recognize multiple antigens.

Kallan AA, Roep BO, Arden SD, Hutton JC, de Vries RR.

J Autoimmun. 1995 Dec;8(6):887-99.

PMID:
8824713
18.

Tetramer-guided epitope mapping reveals broad, individualized repertoires of tetanus toxin-specific CD4+ T cells and suggests HLA-based differences in epitope recognition.

James EA, Bui J, Berger D, Huston L, Roti M, Kwok WW.

Int Immunol. 2007 Nov;19(11):1291-301. Epub 2007 Sep 30.

PMID:
17906339
19.

Visualizing antigen specific CD4+ T cells using MHC class II tetramers.

James EA, LaFond R, Durinovic-Bello I, Kwok W.

J Vis Exp. 2009 Mar 6;(25). pii: 1167. doi: 10.3791/1167.

20.

Islet-specific glucose-6-phosphatase catalytic subunit-related protein-reactive CD4+ T cells in human subjects.

Yang J, Danke NA, Berger D, Reichstetter S, Reijonen H, Greenbaum C, Pihoker C, James EA, Kwok WW.

J Immunol. 2006 Mar 1;176(5):2781-9.

Supplemental Content

Support Center